Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Taxes: 2023-2025

Historic Current Taxes for Catalyst Pharmaceuticals (CPRX) over the last 1 years, with Sep 2025 value amounting to $710,000.

  • Catalyst Pharmaceuticals' Current Taxes was N/A to $710,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $710,000, marking a year-over-year change of. This contributed to the annual value of $894,000 for FY2024, which is 22.63% up from last year.
  • As of Q3 2025, Catalyst Pharmaceuticals' Current Taxes stood at $710,000, which was up 61.73% from $439,000 recorded in Q2 2025.
  • Catalyst Pharmaceuticals' 5-year Current Taxes high stood at $11.1 million for Q1 2025, and its period low was $15,000 during Q2 2024.
  • For the 3-year period, Catalyst Pharmaceuticals' Current Taxes averaged around $2.3 million, with its median value being $719,500 (2023).
  • Data for Catalyst Pharmaceuticals' Current Taxes shows a peak YoY surged of 2,826.67% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Catalyst Pharmaceuticals' Current Taxes stood at $729,000 in 2023, then grew by 22.63% to $894,000 in 2024, then spiked by 2,826.67% to $710,000 in 2025.
  • Its Current Taxes stands at $710,000 for Q3 2025, versus $439,000 for Q2 2025 and $11.1 million for Q1 2025.